X

Vous n'êtes pas connecté

Articles similaires

Sorry! Image not available at this time

NUPRC Threatens Sanction For Oil Companies Violating Domestic Supply Obligation

arise.tv - 04/Feb 06:01

NUPRC has threatened sanctions for oil firms deliberately failing to meet domestic crude supply obligations to refineries.

Sorry! Image not available at this time

Cocoa board to focus on domestic supply chain in 2025 - Johari Ghani

nst.com.my - 10/Feb 23:31

KOTA KINABALU: The Malaysian Cocoa Board (MCB) will focus on strengthening the domestic cocoa supply chain for this year, said the Plantation...

Sorry! Image not available at this time

PSG's crushing domination leaves no hope for domestic rivals

nst.com.my - 07/Feb 14:53

PARIS: Paris Saint-Germain head into the Champions League knockout phase in rude health, with their crushing domination against domestic opposition...

Sorry! Image not available at this time

Nigeria to Block Oil Exports for Producers Missing Domestic Supply Quotas

iafrica.com - 06/Feb 06:17

Nigeria’s upstream oil regulator has announced that it will withhold export permits for oil cargoes from producers who do not meet their domestic...

Ludhiana: Officials told to take NOCs in advance for water supply project

hindustantimes.com - 14/Feb 01:14

As the designing works are going on under the first phase of the project, NOCs are being obtained in advance so that there is no delay later

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

pressarabia.qa - 05/Feb 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

emiratesnewswire.com  - 05/Feb 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

varabnewsexpress.ae  - 05/Feb 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...